TIDMALK
RNS Number : 2531E
Alkemy Capital Investments PLC
27 October 2022
27 October 2022
Alkemy Capital Investments plc
Interim Results for the Six Months Ended 31 July 2022
Alkemy Capital Investments plc ("ALK" or the "Company")
(ALK:LSE) (JV2:FRA) is pleased to present its unaudited financial
statements for the 6 months ended 31 July 2022 as extracted from
the Company's 2022 Half Year Report which is now available on the
Company website at www.alkemycapital.co.uk.
The interim financial statements are set out below and should be
read in conjunction with the 2022 Half Year Report which contains
the notes to the financial statements.
2022 Financial and Operational Highlights include:
-- Tees Valley Lithium officially launched
-- Class 4 feasibility study delivered for our lithium hydroxide processing facility in Teesside
-- Met test work confirms ultra-pure battery-grade lithium hydroxide
-- Partnerships established with Traxys and Weardale Lithium for feedstock
-- Australia strategy launched
-- Key consultants appointed and management positions filled
-- Oversubscribed private placement completed
-- Partnership established with bp for green hydrogen use
Further information
For further information, please visit Alkemy's website:
www.alkemycapital.co.uk or TVL's website
www.teesvalleylithium.co.uk .
-Ends-
Alkemy Capital Investments Plc Tel: 0207 317 0636
Sam Quinn info@alkemycapital.co.uk
Buchanan Tel: +44 (0)20 7466 5000
Bobby Morse/Abigail Gilchrist TVL@buchanan.uk.com
VSA Capital Limited Tel: 0203 005 5000
Andrew Monk (Corporate Broking)
Andrew Raca (Corporate Finance)
Shard Capital Partners LLP Tel: 0207 186 9952
Damon Heath damon.heath@shardcapital.com
Tel: 0207 186 9927
Isabella Pierre isabella.pierre@shardcapital.com
Chairman's Statement
I have great pleasure in presenting our interim results for the
period ended 31 July 2022.
Highlights:
-- Tees Valley Lithium officially launched
-- Class 4 feasibility study delivered for our lithium hydroxide processing facility in Teesside
-- Met test work confirms ultra-pure battery-grade lithium hydroxide
-- Partnerships established with Traxys and Weardale Lithium for feedstock
-- Australia strategy launched
-- Key consultants appointed and management positions filled
-- Oversubscribed private placement completed
-- Partnership established with bp for green hydrogen use
Tees Valley Lithium
In February 2022 we announced the formation of a subsidiary
called Tees Valley Lithium Limited ("TVL").
TVL will seek to develop the UK's first lithium hydroxide
monohydrate ("LHM") facility at the Wilton International Chemicals
Park located in the Teesside Freeport, UK.
This transaction and change of strategy constituted a reverse
takeover transaction under the listing rules of the London Stock
Exchange and resulted in Alkemy becoming an operating company.
Although we are still in the early stages, our aim is to build
the most sustainable and significant producer of lithium hydroxide
globally, utilising the advantages of the UK's chemical processing
skills, infrastructure, green energy and legislation.
Class 4 Feasibility Study
In April 2022 we announced the completion of a Class 4
Feasibility Study for our LHM facility. The LHM facility will
process feedstock imported from various sources to produce 96,000
tonnes of a premium, low-carbon lithium hydroxide annually,
representing around 15% of Europe's projected demand.
The proposed LHM facility is located at the "plug and play"
Wilton International Chemicals Park in the Teesside Freeport, with
connections to 100% certified renewable energy.
The study was prepared by Wave International, a leading
engineering consultancy firm with significant experience in
developing lithium hydroxide projects worldwide.
Study highlights:
-- 96,000 tonnes annual production of battery grade lithium
hydroxide representing approximately 15% of projected UK and EU
demand;
-- The facility has been designed to process a range of imported
low-carbon, high value feed sources including lithium sulphate and
lithium carbonate;
-- Pre-tax net present value (NPV) of GBP2.8 (US$3.9) billion
based on long-term lithium hydroxide price of US$25,000 per
tonne;
-- Initial capital cost of GBP216 (US$300) million;
-- Gross revenues of GBP49.2 (US$68.4) billion;
-- Internal rate of return (IRR) of 35.6%;
-- Significant potential to capture by-product value streams.
The project is the first of its kind in the UK, the biggest in
Europe and will when completed be a key supplier to UK and European
giga factories, electrical vehicle and battery storage
industries.
Metallurgical test work
In May 2022 we announced the initial results of our ongoing
metallurgical test-work programme. The test-work was performed by a
leading technology provider JordProxa in Australia and
independently verified by an internationally recognised cathode
active material manufacturer.
The results demonstrated an ultra-pure battery grade lithium
hydroxide from a low-quality industrial grade (95%) lithium
sulphate.
The product specification rivals the prevalent Chinese standard
specification GB/T 26008-2020 D1.
JordProxa further confirmed the ability to upscale to commercial
production.
Feedstock and partnerships
During the period we continued to advance our discussions with
counterparties for both feedstock and offtake.
In July 2022 we signed a partnership agreement with Traxys, a
leading global physical trader and merchant in metals and natural
resources, with annual turnover in excess of USD 8 billion. Under
the terms of the agreement, Traxys will source and supply lithium
feedstock for our processing facilities.
In August 2022 we announced the signing of an MoU with Weardale
Lithium as a potential feedstock supplier from its lithium project
in the North-East of England.
We are currently in advanced discussions with several other
potential suppliers of spodumene concentrate and crude lithium
carbonate and look forward to updating the market on this in due
course.
Australia strategy
In August 2022 we announced plans to build a lithium sulphate
monohydrate ("LSM") plant at Port Hedland, Australia's largest
export port located in the Pilbara region of Western Australia, to
feed TVL's LHM facility in Teesside.
Port Hedland is an ideal location as it is in close proximity to
a large number of spodumene producers in Western Australia. Port
Hedland also benefits from excellent existing infrastructure (road,
rail, water, electricity and gas) as well as talent. It further
benefits from access to renewable energy and energy storage,
allowing the delivery of a LSM plant with a low carbon
footprint.
Train 1 of the Port Hedland LSM plant will process spodumene
from Australian lithium miners to produce 40,000 tpa of primary
LSM, with trains 2-4 adding a further 120,000 tpa primary LSM
production in future expansions.
The Port Hedland LSM plant, together with TVL's LHM processing
facility at Teesside, will deliver a low carbon, de-risked lithium
supply chain between Western Australian spodumene producers and the
burgeoning European lithium battery cell market.
Key consultants and management team
In March 2022 we strengthened our management team with the
addition of John Walker as the chief executive officer of TVL. John
has more than 30 years of leadership experience in the mining and
advanced materials processing industries.
In October 2022 we further bolstered the team with the
appointment of Tony Veitch to lead our LSM project development.
Tony is a very capable and experienced project builder and we are
pleased to retain such talent on our team.
We have also appointed several industry leading consultants to
help us deliver the projects, including:
-- Wave International - a leading consulting firm in the battery
and tech metals sector, with extensive upstream and downstream
lithium processing experience. Wave delivered the Class 4 study and
have had a significant involvement in the development of lithium
hydroxide refineries in Australia. Wave will manage all work
programmes including the work of our other experts and consultants,
in order to develop a best-in-class LSM and LHM refining
process.
-- ANZAPLAN - a leading engineering consultant who will assist
TVL in the development of the electrochemical route process.
-- Nagrom laboratories - a leading laboratory who will advise on the removal of impurities.
We expect to make further appointments as the projects develop
and will keep the market updated on this front.
Funding
In August 2022 we completed a successful private placing raising
GBP1.2 million. The placing was oversubscribed and supported by
existing and new investors as well as by the directors.
We are also advancing discussions with financiers for the
funding of its LSM and LHM processing facilities and has received
significant inbound interest including from private equity,
structured bond providers and institutions.
As we intend to primarily finance and operate the LSM and LHM
facilities via our operating subsidiary TVL, it is anticipated that
there will be no significant dilution to Alkemy's shareholders as
part of the proposed financing process.
Partnership with bp for use of green hydrogen
In October 2022 we announced an MOU with bp Alternative Energy
Investments who will seek to supply green hydrogen to TVL as part
of bp's Hygreen hydrogen project which is currently under
development. As part of this partnership, TVL and bp will evaluate
the feasibility of further decarbonising TVL's processes and energy
requirements via a switch from natural gas to green hydrogen.
Agreement to Lease at Wilton International
In September 2022 we announced an extension to the exclusivity
period with Sembcorp Energy UK until 31 October 2022 to facilitate
ongoing discussions with the aim of concluding legal documentation
for the Agreement to Lease at Wilton International. We will provide
further updates as and when there are any developments to
report.
Market recognition and outlook
During the period we hosted a number of site visits in Teesside
for brokers, investors and partners. The site visits were very well
received and demonstrated to our guests the excellent facilities at
Wilton International and at Teesside.
During the period we also engaged brokers Shard Capital and VSA
Capital, who both produced detailed research notes which were
highly supportive of our project.
The pace to decarbonise is accelerating and with a growing need
for lithium hydroxide and now a growing preference from western
OEM's to source lithium hydroxide using more local supply chains,
Alkemy is well positioned to benefit from these changes.
We would like to take this opportunity to thank our shareholders
for their continued support and look forward to reporting on our
progress during 2022 as we deliver on our strategy.
Paul Atherley
Non-Executive Chairman
27 October 2022
STATEMENT OF COMPREHENSIVE INCOME
for the period ended 31 July 2022
For six For the For
months six months period
ended ended 31 ended 31
31 July July 2021 January
2022 (unaudited) 2022
(unaudited) (audited)
GBP GBP GBP
Note
Administrative expenses (708,890) (38,600) (466,903)
Project Development
costs (649,397) - (330,747)
Foreign exchange -
gains / (losses) (7,777) -
------------ -------------------- ----------
Operating profit (1,366,064) (38,600) (797,650)
Finance costs (1,535) (49) -
------------ -------------------- ----------
Loss before taxation (1,367,599) (38,649) (797,650)
Income tax - - -
------------ -------------------- ----------
Loss after taxation (1,367,599) (38,649) (797,650)
Other Comprehensive
income
Exchange gains /
(losses) on translation -
of foreign operations (978) -
------------ -------------------- ----------
Total other comprehensive
income (978) - -
Total comprehensive
loss
for the year (1,368,577) (38,649) (797,650)
------------ -------------------- ----------
Earnings per share 9
Basic and diluted ( GBP per
share) (0.228) (0.013) (0.199)
------------ -------------------- ----------
The accompanying notes form an integral part of the financial
information.
STATEMENT OF FINANCIAL POSITION
As at 31 July 2021
Note At 31 At 31 At 31
July 2022 July 2021 January
(unaudited) (unaudited) 2022 (audited)
GBP GBP GBP
ASSETS
Current assets
Trade and other receivables 8 15,197 - 73
Restricted cash 6,598 - -
Cash and cash equivalents 13,242 729,904 1,113,923
------------- ------------- ----------------
Total assets 35,037 729,904 1,113,996
------------- ------------- ----------------
EQUITY
Equity Attributable to Owners
of the company
Share capital 10 120,000 60,000 120,000
Share premium 1,279,094 - 1,279,094
Foreign exchange reserve (978) - -
Retained earnings (2,165,249) (38,649) (797,650)
------------- ------------- ----------------
Total equity (767,133) 21,351 601,444
------------- ------------- ----------------
LIABILITIES
Current liabilities
Trade and other payables 11 635,911 38,600 512,552
Borrowings 166,259 669,953 -
------------- ------------- ----------------
Total current liabilities 802,170 708,553 512,552
------------- ------------- ----------------
TOTAL EQUITY AND LIABILITIES 35,037 729,904 1,113,996
------------- ------------- ----------------
The accompanying notes form an integral part of the financial
information.
This report was approved by the board and authorised for issue
on 27 October 2022 and signed on its behalf by:
Paul Atherley
Non-Executive Chairman
STATEMENT OF CHANGES IN EQUITY
for the year ended 31 January 2022
Share Share Foreign Retained Total
capital premium exchange earnings equity
GBP GBP GBP GBP GBP
Balance at incorporation - - - - -
on 21 January 2021
Total comprehensive
loss for the period - - - (38,649) (38,649)
-------- ---------- ------ ------------ -------------
Total comprehensive
income for the period - - - (38,649) (38,649)
Transactions with
owners
Shares issued on incorporation 60,000 - - - 60,000
-------- ---------- ------ ------------ -------------
Total Transactions
with owners 60,000 - - - 60,000
Balance at 31 July
2021 (unaudited) 60,000 - - (38,649) 21,351
-------- ---------- ------ ------------ -------------
Balance at 1 February
2022 120,000 1,279,094 - (797,650) 601,444
-------- ---------- ------ ------------ -------------
Total comprehensive
loss for the period - - - (1,367,599) (1,367,599)
Unrealised foreign
currency loss arising
on translation of
foreign operations - - (978) - (978)
-------- ---------- ------ ------------ -------------
Total comprehensive
income for the period - - (978) (1,367,599) (1,368,577)
-------- ---------- ------ ------------ -------------
Balance at 31 July
2022 (unaudited) 120,000 1,279,094 (978) (2,165,249) (767,133)
-------- ---------- ------ ------------ -------------
The accompanying notes form an integral part of the financial
information.
STATEMENT OF CASHFLOWS
for the period ended 31 July 2022
Six months Six months Year
ended ended ended
31 July 31 July 31 January
2022 (unaudited) 2021 (unaudited) 2021 (audited)
GBP GBP GBP
Loss before tax (1,367,599) (38,649) (797,650)
Adjusted for:
(Increase)/decrease in
receivables (15,124) - (73)
(Decrease)/Increase in
trade creditors 123,197 38,600 512,552
------------------ ---------------------- -------------------
Net cash used in operating
activities (1,259,526) (49) (285,171)
Financing activities
Increase in restricted (6,598)
funds - -
Cash from issue of Ordinary
shares - 60,000 1,399,094
Proceeds from short term
borrowings 166,259 669,953 -
------------------ ---------------------- -------------------
Net cash from financing
activities 159,661 729,953 1,399,094
Net (decrease)/increase
in cash and cash equivalents (1,099,865) 729,904 1,113,923
------------------ ---------------------- -------------------
Cash and cash equivalents
at beginning of the year 1,113,923 - -
Effects of foreign exchange
on cash balances (816)
------------------ ---------------------- -------------------
Cash and cash equivalents
at end of the year 13,242 729,904 1,113,923
------------------ ---------------------- -------------------
The accompanying notes form an integral part of the financial
information.
NOTES TO THE FINANCIAL INFORMATION
1. GENERAL INFORMATION
The Company was incorporated on 21 January 2021 in England and
Wales as a public company, limited by shares and with Registered
Number 13149164 under the Companies Act 2006. On incorporation, the
Company's name was Alkemy Capital Plc. On 4 February 2021, the
Company's name was changed to Alkemy Capital Investments Plc. The
Company's registered office address is 167-169 Great Portland
Street, Fifth Floor, London W1W 5PF. On 25 February 2022 the
Company formed a wholly owned subsidiary called Tees Valley Lithium
Limited, a company seeking to establish a Lithium Hydroxide
Monohydrate ("LHM") processing facility in Teesside, UK.
The Company's objective is to establish a LHM processing plant
at its chosen site in Teeside, UK which will aim to initially
produce LHM from lithium feedstock from various sources, to be sold
to the UK and European mobile energy markets . In August 2022 the
Company announced plans to build a lithium sulphate monohydrate
plant at Port Hedland, Australia's largest export port located in
the Pilbara region of Western Australia, to feed TVL's LHM facility
in Teesside.
Other than the Directors, the Company has no employees.
The Directors who served during the period were Sam Quinn, Paul
Atherley and Helen Pein.
2. ACCOUNTING POLICIES
Basis of preparation
The principal accounting policies adopted by the Company in the
preparation of the Company Financial Information are set out
below.
The Company Financial Information has been presented in GBP,
being the functional currency of the Company.
The Company Financial Information has been prepared in
accordance with IFRS, including interpretations made by the
International Financial Reporting Interpretations Committee issued
by the International Accounting Standards Board. The standards have
been applied consistently. The historical cost basis of preparation
has been used.
The preparation of the financial statements in conformity with
IFRS requires the use of certain critical accounting estimates. It
also requires the Directors to exercise their judgment in the
process of applying the Company's accounting policies.
In the opinion of the management, the interim unaudited
financial information includes all adjustments considered necessary
for fair and consistent presentation of this financial information.
The interim unaudited financial information should be read in
conjunction with the Company's audited financial statements and
notes for the year ended 31 January 2022.
Standards and interpretations issued but not yet applied
A number of new standards and amendments to standards and
interpretations have been issued but are not yet effective and, in
some cases, have not yet been adopted by the UKEU. The Directors do
not expect that the adoption of these standards will have a
material impact on the Company Financial Information.
Going Concern
The Company Financial Information has been prepared on a going
concern basis.
The Company's assets are comprised almost entirely of cash. The
Directors have outlined their new strategy for the Company in the
Chairman's Statement. As part of their assessment of going concern,
the Directors have prepared cash forecasts to determine the cash
requirements of the business as it continues to deliver on its
strategy.
In order for the Company to be successful in its strategy, it
will need to raise additional funds in the immediate term. The
Directors are reasonably confident that such funds will be
forthcoming as and when they are required, however as successful
future fundraising in support of this strategy cannot be assured, a
material uncertainty exists in this regard. The Directors have a
reasonable expectation that the Company shall be able to secure
adequate resources to continue in operational existence for the
foreseeable future.
Accordingly, the Directors believe that as at the date of this
report it is appropriate to continue to adopt the going concern
basis in preparing the financial statements.
Financial assets
Financial assets and financial liabilities are recognised when
the Company becomes a party to the contractual provisions of a
financial instrument. Financial assets and financial liabilities
are offset if there is a legally enforceable right to set off the
recognised amounts and interests and it is intended to settle on a
net basis. Cash comprises cash in hand and on demand deposits. Cash
equivalents are short-term, highly liquid investments that are
readily convertible to known amounts of cash and that are subject
to an insignificant risk of changes in value with maturities of
less than 90 days.
Financial liabilities
The Company does not currently have any financial liabilities
measured at fair value through profit or loss, therefore all
financial liabilities are initially measured at fair value, net of
transaction costs, and are subsequently measured at amortised cost.
The Company recognises an equity instrument on any contract that
evidences a residual interest in the assets of the Company. In this
period Ordinary Shares were the only equity instrument, recognised
at the point at which a call is made on the Shareholders.
Earnings per Ordinary Share
The Company presents basic and diluted earnings per share data
for its Ordinary Shares. Basic earnings per Ordinary Share is
calculated by dividing the profit or loss attributable to
Shareholders by the weighted average number of Ordinary Shares
outstanding during the period. Diluted earnings per Ordinary Share
is calculated by adjusting the earnings and number of Ordinary
Shares for the effects of dilutive potential Ordinary Shares.
3. USE OF ASSUMPTIONS AND ESTIMATES
In preparing the Company Financial Information, the Directors
have to make judgments on how to apply the Company's accounting
policies and make estimates about the future. The Directors do not
consider there to be any critical judgments that have been made in
arriving at the amounts recognised in the Company Financial
Information.
4. DIRECTORS' EMOLUMENTS
Directors' Consultancy
fees fees Social Security Total
31 July 2022 GBP'000 GBP'000 GBP'000 GBP'000
------------- ---------- ----------- --------------- --------
P Atherley 12,000 27,000 1,096 40,096
S Quinn 10,500 18,600 769 29,869
H Pein 9,000 - - 9,000
Total 31,500 45,600 1,865 78,965
------------- ---------- ----------- --------------- --------
No amount was paid or became payable to any of the Directors of
the Company in the prior period, and there were no staff costs as
no staff was employed by the Company during the prior period.
5. FINANCIAL RISK MANAGEMENT
The Company uses a limited number of financial instruments,
comprising cash and various items such as trade payables, which
arise directly from operations. The Company does not trade in
financial instruments.
Financial risk factors
The Company's activities expose it to a variety of financial
risks: credit risk and liquidity risk. The Company's overall risk
management programme focuses on the unpredictability of financial
markets and seeks to minimise potential adverse effects on the
Company's financial performance.
(a) Credit risk
The Company does not have any major concentrations of credit
risk related to any individual customer or counterparty.
(b) Liquidity risk
Prudent liquidity risk management implies maintaining sufficient
cash, the Company ensures it has adequate resource to discharge all
its liabilities. The directors have considered the liquidity risk
as part of their going concern assessment.
Fair values
Management assessed that the fair values of other receivables
approximate their carrying amounts largely due to the short-term
maturities of these instruments.
6. CAPITAL MANAGEMENT POLICY
The Company's objectives when managing capital are to safeguard
the Company's ability to continue as a going concern in order to
provide returns for shareholders and benefits for other
stakeholders and to maintain an optimal capital structure to reduce
the cost of capital. The capital structure of the Company consists
of equity attributable to equity holders of the Company, comprising
issued share capital and reserves.
7. FINANCIAL INSTRUMENTS
The Company's principal financial instruments comprise other
receivables. The Company's accounting policy and method adopted,
including the criteria for recognition, the basis on which income
and expenses are recognised in respect of this financial asset. The
Company does not use financial instruments for speculative
purposes.
There are no financial assets that are either past due or
impaired.
8. TRADE AND OTHER RECEIVABLES
31 July 31 July
2021 2021
GBP GBP
Prepayments 15,197 -
9. EARNINGS PER SHARE
The loss per share has been calculated using the loss for the
year and the weighted average number of ordinary shares entitled to
dividend rights which were outstanding during the year. There were
no potentially dilutive ordinary shares at the year end.
31 July 31 July
2022 2021
GBP GBP
Loss for the period attributable to equity holders of the Company (1,367,599) (38,649)
Weighted average number of ordinary shares (number of shares) 5,999,999 3,000,000
-------------- ------------
Loss per share ( GBP per share) (0.228) (0.013)
-------------- ------------
10. SHARE CAPITAL
Ordinary shares of GBP0.02 each
Number Amount
of shares GBP
Issued, called up and paid - 31 July
2022 5,999,999 120,000
5,999,999 120,000
----------- --------
Number Amount
of shares GBP
Issued, called up and paid - 31 July
2021 3,000,000 60,000
3,000,000 60,000
----------- -------
On incorporation on 21 January 2021, the Company issued
3,000,000 Ordinary Shares of GBP0.02 nominal value.
On 27 September 2021, 2,999,999 ordinary shares were issued for
cash at 50p per share, raising GBP1,500,000 before expenses of
GBP160,906
No further issues of Ordinary Shares were made during the
period.
11. TRADE AND OTHER PAYABLES
31 July 31 July
2022 2021
GBP GBP
-------------------------------- -------- --------
Trade payables 579,489 38,600
Other payables 41,357 -
Accrued expenses 15,064 -
-------------------------------- -------- --------
Total trade and other payables 635,910 38,600
-------------------------------- -------- --------
12. POST BALANCE SHEET EVENTS
On 21 July 2022 the Company announced that it had entered into
an MOU with Traxys North America LLC pursuant to which Traxys has
agreed to source and supply lithium feedstock for TVL's planned
processing facility in Teesside.
On 4 August 2022 the Company announced a placing of 1.2m new
ordinary shares to raise gross proceeds of GBP1.2m, of which
GBP178,000 of these shares were subscribed for by the
directors.
On 4 August 2022 the Company announced the grant of 590,000
options to subscribe for ordinary shares in the Company at GBP1 per
share to the directors and senior management.
On 8 August 2022 the Company announced plans to construct a
Lithium Sulphate processing plant in Port Headland, Western
Australia. The project will act as a refining hub for Australian
lithium producers and provide a key feedstock for the Company's
Teesside LHM processing plant. The Company also announced the grant
of a further 100,000 options to consultants.
On 15 August 2022 the Company announced the signing of an MOU
with Weardale Lithium to evaluate the potential to supply lithium
feedstock.
On 29 September 2022 the Company announced the appointment of
Tony Veitch to lead the development of the Port Hedland project,
the listing of the Company's shares on the Frankfurt Stock
Exchange, the extension of the Exclusivity Agreement for the site
at Wilton International to 31 October 2022 and the grant of a
further 100,000 options to consultants.
On 12 October 2022 the Company announced that it had entered
into an MOU with bp Alternative Energy Investments Limited for the
supply of green hydrogen to the Company's LHM processing plant in
Teesside, UK.
13. ULTIMATE CONTROLLING PARTY
As at 31 July 2022, the ultimate controlling party of the
Company was Paul Atherley.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
IR BCBDGDBDDGDL
(END) Dow Jones Newswires
October 27, 2022 02:00 ET (06:00 GMT)
Alkemy Capital Investments (LSE:ALK)
Historical Stock Chart
From Mar 2024 to Apr 2024
Alkemy Capital Investments (LSE:ALK)
Historical Stock Chart
From Apr 2023 to Apr 2024
